Abstract: A Data Security Management System using a communications interface configured to receive and transmit one or more portions of Post Quantum Resistant Encrypted data within a network comprising a plurality of endpoints. Using End-to-End (E2E) Post Quantum Resistant encryption techniques to protect the data, the Data Security Management System provides the flexibility for multiple data schemes in a distributive environment such as, but not limited to, Hyperledger. The system uses a Policy Manager to perform the base configuration of the session to be transmitted or received in an encrypted state. This encrypted state comprises Post Quantum Cryptographic algorithm in use for that session, inclusive with associated keys or digital signatures. The Policy Manager is further configured to verify an identity of endpoint by a multifactor cryptographic authentication mechanism or a biometric authentication mechanism to validate a connection to or from an endpoint.

Abstract: Skeletonized blood vessels for use as vascular grafts are protected from biomechanical injury and/or certain cellular and extracellular changes by application of a biocompatible hydrogel to the vessel exterior. The hydrogel may be applied to the vessel graft before or after harvesting from a donor patient.

Abstract: The invention relates to peptide conjugates that can bind to endothelial cells, and that are useful for reducing the incidence and severity of endothelial dysfunction in mammals.

Abstract: Compositions and methods are provided for treating a patient suffering from a disease associated with endothelial dysfunction by administering to the patient a pharmaceutical composition containing an effective amount of a synthetic collagen binding peptidoglycan.

Abstract: Skeletonized blood vessels for use as vascular grafts are protected from biomechanical injury and/or certain cellular and extracellular changes by application of a biocompatible hydrogel to the vessel exterior. The hydrogel may be applied to the vessel graft before or after harvesting from a donor patient.

Abstract: The invention relates to peptide conjugates that can bind to endothelial cells, and that are useful for reducing the incidence and severity of endothelial dysfunction in mammals.

Abstract: Compositions and methods are provided for treating a patient suffering from a disease associated with endothelial dysfunction by administering to the patient a pharmaceutical composition containing an effective amount of a synthetic collagen binding peptidoglycan.